Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04

By sjmartinez • July 31, 2024

Peipert JD, Roydhouse J, Tighiouart M, Henry NL, Kim S, Hays RD, Rogatko A, Yothers G, Ganz PA. Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04. Qual Life Res. 2024 Jul 30. doi: 10.1007/s11136-024-03746-5. Epub ahead of print. PMID: 39080091.

Tags: Cancer, Cedars Sinai DoM, clinical trials, FACT GP5, General Internal Medicine, Hematology/Oncology, Publications, Treatment tolerability

ERCP first vs. surgery first: A comparative perspective in pediatric choledocholithiasis

Judy W, Gomez MK, Liu Q, Neff L. ERCP first vs. surgery first: A comparative perspective in pediatric choledocholithiasis. Semin Pediatr Surg. 2025 Jun 29;34:151501.[...]

A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma

Amaral LJ, Gresham G, Kim S, Tighiouart M, Nelson TA, Welborn A, Lockshon L, Noorvash B, Rudnick JD, Irwin SA, Freedland SJ, Hu J. A[...]

Impact and management of warm autoimmune haemolytic anaemia associated with systemic lupus erythematosus

Pons-Estel GJ, Mosca M, Wallace DJ, Zazzetti F, Leon A, Noël W, Pierce A, Ebrahim T, Murakhovskaya I. Impact and management of warm autoimmune haemolytic[...]